Form 4: Kronos Bio CEO Norbert Bischofberger Increases Stake in Company
SEC Form 4 Filing
Norbert Bischofberger, the President and CEO of Kronos Bio, Inc., recently acquired additional shares of the company's common stock through multiple transactions.
Summary
- On June 27, 2024, Norbert W. Bischofberger, President & CEO of Kronos Bio, Inc., purchased 410,848 shares of common stock at a weighted average price of $1.1655, with prices ranging from $0.9899 to $1.20.
- On June 28, 2024, Bischofberger purchased an additional 204,670 shares of common stock at a weighted average price of $1.2457, with prices ranging from $1.18 to $1.25.
- Following these transactions, Bischofberger directly and indirectly owns 10,802,138 shares.
- A portion of these shares are held in the Norbert W. & Inger A. Bischofberger Revocable Inter Vivos Trust.
- Additional shares are held in various Dynasty GST Exempt and Non-Exempt Trusts.
Sentiment
Score: 7
Explanation: The document primarily reflects insider buying, which is generally viewed as a positive signal. However, it's important to consider the context and reasons behind the purchase.
Positives
- The CEO's purchase of additional shares may signal confidence in the company's future prospects.
Industry Context
Insider buying is often viewed positively by the market, as it suggests that a company's leadership believes the stock is undervalued.
Stakeholder Impact
- Shareholders may view the CEO's stock purchases as a positive sign, potentially increasing investor confidence.
Key Dates
| Date | Description |
|---|---|
| August 29, 1994 | Date of the Norbert W. & Inger A. Bischofberger Revocable Inter Vivos Trust |
| April 29, 2020 | Date of The David Michael Anthony Dynasty GST Exempt Trust |
| April 29, 2020 | Date of The David Michael Anthony Dynasty GST Non-Exempt Trust |
| April 29, 2020 | Date of The Irene Alisha Bischofberger Dynasty GST Exempt Trust |
| April 29, 2020 | Date of The Irene Alisha Bischofberger Dynasty GST Non-Exempt Trust |
| 06/27/2024 | Date of first reported transaction: purchase of 410,848 shares. |
| 06/28/2024 | Date of second reported transaction: purchase of 204,670 shares. |
| 07/01/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.